WHO / Barry Christianson
Nurse Gayiza talks to a colleague as they prepare to open the FastPrep mobile clinic at Phillippi Plaza in Cape Town on 23 May 2024.

© Credits

Lenacapavir approved in Zambia and Zimbabwe in record time through WHO Collaborative Registration Procedure

Informed reliance speeds national approvals, bringing innovative HIV prevention to people faster

1 December 2025

Departmental update

Related

WHO-Listed Authority (WLA)

Collaborative Registration Procedure for medical products

Global HIV Programme

More

Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis